69 coding-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" "Dr" positions at King's College London
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. More information on the department and the programme is available at the departmental prospectus page here: https://www.kcl.ac.uk/study/postgraduate-research/areas/forensic-and-neurodevelopmental-science
-
community in Europe devoted to the study and prevention of mental illness and brain disease. The IoPPN pioneers research into new and improved ways of understanding and treating mental ill health ( http
-
The Faculty of Arts is internationally leading for its research (https://www.arts.kuleuven.be/english/research ), home to a broad array of specializations and notable for the strong connection it
-
community in Europe devoted to the study and prevention of mental illness and brain disease. The IoPPN pioneers research into new and improved ways of understanding and treating mental ill health ( http
-
SNP linked with increased ALS risk. The successful candidate will work within the vibrant Department of Basic and Clinical Neuroscience under the supervision of clinician scientist Dr Jemeen Sreedharan
-
also visit Dr Vincenzo Abbate’s website for more information: Vincenzo Abbate - King's College London Application deadline: For prospective students interested in our PhD project, applications
-
, you will be part of an active research programme in the Heat and Fire Lab ( https://heatandfire.github.io/ ) in the Department of Engineering under the supervision of Dr Francesco Restuccia. Our group
-
groundbreaking symbiosis of cutting-edge AI combined with human support. To learn more please visit https://www.kcl.ac.uk/research/embrace About the role The Research Fellow in Digital Health & Data Sciences is
-
in Europe devoted to the study and prevention of mental illness and brain disease. The IoPPN pioneers research into new and improved ways of understanding and treating mental ill health (http
-
. This role will oversee a Phase 2/3 multi-arm, multi-stage (MAMS) trial evaluating the safety and efficacy of repurposed biosimilars and biologics in adults with epidermolysis bullosa (EB). https